These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36056580)

  • 1. Lung function in Lolland-Falster Health Study (LOFUS).
    Jacobsen KK; Jepsen R; Bodtger U; Rasmussen K; St-Martin G
    Clin Respir J; 2022 Oct; 16(10):657-668. PubMed ID: 36056580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of Different Spirometry Reference Equations and Diagnostic Criteria on the Frequency of Airway Obstruction in Adult People of North China.
    Xie M; Cui L; Liu J; Wang W; Li J; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2020; 15():651-659. PubMed ID: 32273694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria.
    Grafino M; Todo-Bom F; Lutas AC; Cabral J; Pereira M; Valença J; Furtado ST
    J Bras Pneumol; 2022; 47(6):e20210124. PubMed ID: 35019054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.
    Miller MR; Haroon S; Jordan RE; Sitch AJ; Dickens AP; Enocson A; Fitzmaurice DA; Adab P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1979-1986. PubMed ID: 29950827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.
    Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
    Chest; 2005 May; 127(5):1560-4. PubMed ID: 15888828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.
    Akkermans RP; Berrevoets MA; Smeele IJ; Lucas AE; Thoonen BP; Grootens-Stekelenburg JG; Heijdra YF; van Weel C; Schermer TR
    BMC Pulm Med; 2012 Mar; 12():12. PubMed ID: 22439763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.
    Perez-Padilla R; Wehrmeister FC; Celli BR; Lopez-Varela MV; Montes de Oca M; Muiño A; Talamo C; Jardim JR; Valdivia G; Lisboa C; Menezes AM;
    PLoS One; 2013; 8(8):e67960. PubMed ID: 23936297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
    Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.
    Huprikar NA; Skabelund AJ; Bedsole VG; Sjulin TJ; Karandikar AV; Aden JK; Morris MJ
    Respir Care; 2019 Jul; 64(7):786-792. PubMed ID: 30890630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.
    Dharmage SC; Bui DS; Walters EH; Lowe AJ; Thompson B; Bowatte G; Thomas P; Garcia-Aymerich J; Jarvis D; Hamilton GS; Johns DP; Frith P; Senaratna CV; Idrose NS; Wood-Baker RR; Hopper J; Gurrin L; Erbas B; Washko GR; Faner R; Agusti A; Abramson MJ; Lodge CJ; Perret JL
    Lancet Respir Med; 2023 Mar; 11(3):273-282. PubMed ID: 36244396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diagnostic criteria on the prevalence of COPD.
    Çolak Y; Løkke A; Marott JL; Lange P; Vestbo J
    Clin Respir J; 2013 Jul; 7(3):297-303. PubMed ID: 23072716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
    Mohamed Hoesein FA; Zanen P; Lammers JW
    Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales.
    Scholes S; Moody A; Mindell JS
    BMJ Open; 2014 Jul; 4(7):e005685. PubMed ID: 25056983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry.
    Quanjer PH; Brazzale DJ; Boros PW; Pretto JJ
    Eur Respir J; 2013 Oct; 42(4):1046-54. PubMed ID: 23520323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study.
    Lenoir A; Fitting JW; Marques-Vidal PM; Vollenweider P; Nicod LP
    Respir Res; 2018 Dec; 19(1):250. PubMed ID: 30545344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.